AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05185986 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based Cognitive Rehabilitation
Description: Home-based Cognitive Rehabilitation is the 3 sessions per week and 8 weeks of cognitive rehabilitation exercises at home. Each session consists of two Pen and paper exercises. Exercises are active in the areas of planning, cognitive organization, cognitive flexibility and working memory. Each session will take 30 to 45 minutes.
Study NCT05185986 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: waiting list group
Description: This group act as the control group and will maintain their physical and cognitive activities as the preintervention. Following the 8 weeks of intervention the home-based pilates and cognitive rehabilitation exercises will be provided to them for their own use.
Study NCT06319690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lion's Breath Technique
Description: Patients receive training in Lion's Breath Technique, emphasizing deep diaphragmatic breathing and controlled exhalation.~Daily supervised Lion's Breath Technique sessions for 20 minutes for 1 week
Study NCT06319690 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chest Percussion Therapy
Description: Trained physiotherapists administer chest percussion therapy to mobilize secretions and improve lung function.~Daily session for 30 minutes for 1 week.
Study NCT06452004 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Validation of AI-DSS in Bangladesh
Description: VIA procedure, taking pre-colouring and post-colouring pictures. First VIA assessment by health worker, followed by AI-DSS assessment. Independent panel of gynaecologists also assessed pictures. The panel assessment serves as reference value to calculate accuracy, sensitivity and specificity of health worker and AI-DSS.
Study NCT06452004 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Validation of AI-DSS in Uganda
Description: VIA procedure, taking pre-colouring and post-colouring pictures. First VIA assessment by health worker, followed by AI-DSS assessment. Independent panel of gynaecologists also assessed pictures. The panel assessment serves as reference value to calculate accuracy, sensitivity and specificity of health worker and AI-DSS.
Study NCT06452004 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Validation of AI-DSS in India
Description: VIA procedure, taking pre-colouring and post-colouring pictures. First VIA assessment by health worker, followed by AI-DSS assessment. Independent panel of gynaecologists also assessed pictures. The panel assessment serves as reference value to calculate accuracy, sensitivity and specificity of health worker and AI-DSS.
Study NCT04916041 — intervention group
Intervention type: DEVICE
Intervention: Cataract surgery with bilateral implantation of the same type of intraocular lens
Description: Cataract surgery with bilateral implantation of the same type of intraocular lens
Study NCT04635683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT04635683 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ublituximab
Description: Given IV
Study NCT04635683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Umbralisib
Description: Given PO
Study NCT06319690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chest Percussion Therapy
Description: Trained physiotherapists administer chest percussion therapy to mobilize secretions and improve lung function.~Daily session for 30 minutes for 1 week.
Study NCT05864859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation
Description: In the simulation session, while 2 participants (1 midwife, 1 pregnant) performed the roles in accordance with the clinical scenario, the performance was recorded in the control room. A Wearable Pregnancy Simulator was worn by the student performing the pregnant role. During the simulation, the participants were able to interact with the facilitators when they had questions. The application time did not exceed 10 minutes.
Study NCT05535634 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Sound Ear Check
Description: Hearing test, measurement of the input impedance of the middle-ear transmission system
Study NCT05267613 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nexium 20mg
Description: Nexium® (Esomeprazole) gastro-resistant granules for oral suspension 10 or 20 mg taken once daily for 8 weeks, and then 10 or 5 mg taken once daily for 16 weeks.
Study NCT05097716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritlecitinib
Description: Ritlecitinib 200 mg provided as four 50 mg oral capsules
Study NCT05097716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolbutamide
Description: Tolbutamide 500 mg provided as one 500 mg oral tablet
Study NCT06333288 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PST-APPLE Watch group
Description: PST combined APPLE Watch is a tailored behavioral intervention that enables college students with AUD to successfully manage and overcome everyday life challenges influencing their alcohol intake and teach problem-solving skills.
Study NCT06333288 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Education-only control group
Description: Education-only control group receives Quit Drinking Motivation 20-min video created by the MotivationHub, followed by a 30-minute group discussion.
Study NCT06292650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZM-02-L
Description: rAAV-PsCatCh2.0 intravitreal injection of low dose
Study NCT06292650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZM-02-H
Description: rAAV-PsCatCh2.0 intravitreal injection of high dose
Study NCT06292650 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: ZM-02-S
Description: sham intravitreal injection of ZM-02 (not actual injection)
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab Deruxtecan
Description: Datopotamab Deruxtecan IV (intravenous)
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rilvegostomig
Description: Rilvegostomig IV (intravenous)
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin IV (intravenous), Active Comparator
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin IV (intravenous), Active Comparator
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoposide
Description: Etoposide IV (intravenous), Active Comparator
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed IV (intravenous), Active Comparator
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vinorelbine
Description: Vinorelbine IV (intravenous), Active Comparator
Study NCT06564844 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: UFT
Description: UFT Oral route of administration, Active Comparator
Study NCT04903106 — intervention group
Intervention type: DEVICE
Intervention: FAST-FIX FLEX Meniscal Repair System
Description: Standard of care surgery in which the meniscus is repaired using FAST-FIX FLEX device.
Study NCT04903106 — intervention group
Intervention type: DEVICE
Intervention: FAST-FIX FLEX Meniscal Repair System
Description: Standard of care surgery in which the FASTFIX FLEX device is used during the meniscal allograft transplantation procedure.
Study NCT04662151 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AT-100
Description: reconstituted AT-100 for intratracheal administration
Study NCT04662151 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Air-sham
Description: room air for intratracheal administration
Study NCT05091723 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nezulcitinib (TD-0903) Dose A
Description: TD-0903 Dose A
Study NCT05091723 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nezulcitinib (TD-0903) Dose B
Description: TD-0903 Dose B
Study NCT04908605 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mirtazapine
Description: Every patient will be given mirtazapine 30 mg tablet
Study NCT05267613 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nexium 10mg
Description: Nexium® (Esomeprazole) gastro-resistant granules for oral suspension 10 or 20 mg taken once daily for 8 weeks, and then 10 or 5 mg taken once daily for 16 weeks.
Study NCT04908605 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin
Description: Every patient will be given melatonin 5 mg tablet
Study NCT04908605 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Every patient will be given a matching placebo tablet
Study NCT05400642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: THRIVE
Description: Apneic ventilation
Study NCT05400642 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: mechanical ventilation
Description: mechanical ventilation in Positive Pressure
Study NCT04866368 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The ultrasound-guided Sacral Erector spinae plane block
Description: postoperative pain procedure
Study NCT04866368 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The dorsal penile block
Description: postoperative pain procedure
Study NCT05990218 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Artificial intellegence. CADe syste,
Description: The patient received endoscopy under CADe system for polyp detection during second endoscopic withdrawal.
Study NCT05990218 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: The patient received endoscopy under conventional white light for polyp detection during second endoscopic withdrawal.
Study NCT06053749 — intervention group
Intervention type: DRUG
Intervention: Avonex (IFNβ-1-a, Biogen Netherlands B.V)
Description: Information on drug use in hospitals and outpatient clinics are not recorded in the drug registers used in the study and, thus, information on exposure to these medications is not available.
Study NCT06053749 — intervention group
Intervention type: DRUG
Intervention: Rebif (IFNβ-1-a, Merck Europe B.V.)
Description: Information on drug use in hospitals and outpatient clinics are not recorded in the drug registers used in the study and, thus, information on exposure to these medications is not available.
Study NCT06053749 — intervention group
Intervention type: DRUG
Intervention: Extavia (IFNβ-1-b, Novartis Europharm Limited)
Description: Information on drug use in hospitals and outpatient clinics are not recorded in the drug registers used in the study and, thus, information on exposure to these medications is not available.
Study NCT06053749 — intervention group
Intervention type: DRUG
Intervention: Betaseron (IFN-β-1-b, BAY86-5046, Bayer AG)
Description: Information on drug use in hospitals and outpatient clinics are not recorded in the drug registers used in the study and, thus, information on exposure to these medications is not available.
Study NCT06053749 — intervention group
Intervention type: DRUG
Intervention: Plegridy (Peg IFNβ-1-a, Biogen Netherlands B.V)
Description: Information on drug use in hospitals and outpatient clinics are not recorded in the drug registers used in the study and, thus, information on exposure to these medications is not available.
Study NCT06053749 — intervention group
Intervention type: DRUG
Intervention: MS disease modifying drugs (MSDMDs)
Description: Information on drug use in hospitals and outpatient clinics are not recorded in the drug registers used in the study and, thus, information on exposure to these medications is not available.
Study NCT05076175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: Specified dose on specified days
Study NCT06294769 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: essencial oil of lavandula angustifolia
Description: The intervention will consist of the application of aromatherapy with 2% lavender essential oil cutaneously and inhalation via by a nurse, associated with usual care, in the immediate postoperative period
Study NCT06294769 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: grape seed vegetable oil
Description: The placebo group will only receive the application of grape seed vegetable oil associated with usual care in the immediate postoperative period.
Study NCT06162494 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Zoster Vaccine
Description: After giving consent, participants will be given first dose of vaccine. Participants will be brought back 60-90 days post-vaccine for follow up testing and second dose of vaccine
Study NCT05011682 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular diet
Description: participant's usual diet during 2 weeks
Study NCT05011682 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 10-point nutrition plan
Description: controlled portions of low glycemic index carbohydrates, avoidance of rapidly absorbed carbohydrates, adjustment of timing of meals and snacks, and attention to personal and cultural barriers to implementation
Study NCT05042518 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiment
Description: breathing control and self-talk with objectives
Study NCT05042518 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: The participant in the control group will receive consultations by a sport psychologist for goal setting and positive thinking. The duration is similar to the training group (4-5 minutes in each session, 4 sessions per week for 1 month)
Study NCT05023343 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 30 mL Ropivacaine 0,75% administered as a unilateral TQL block
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quadriceps muscle strength
Description: Quadriceps muscle strength is assessed using a hand-held dynamometer. Each participant is tested pre block administration and 60 minutes after
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Quadriceps muscle strength
Description: Quadriceps muscle strength is assessed using a hand-held dynamometer. Each participant is tested pre block administration and 60 minutes after
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Timed Up and Go
Description: To test mobilisation the standardised Timed Up and Go test is used. Each participant is tested pre block administration and 60 minutes after
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Timed Up and Go
Description: To test mobilisation the standardised Timed Up and Go test is used. Each participant is tested pre block administration and 60 minutes after
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Single-leg 6 meter timed hop test
Description: To test muscle strength and power the single-leg 6 meter jump test is used. Each participant is tested pre block administration and 60 minutes after
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Single-leg 6 meter timed hop test
Description: To test muscle strength and power the single-leg 6 meter jump test is used. Each participant is tested pre block administration and 60 minutes after
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Temperature discrimination
Description: Dermatomal evaluation of cold and warm discrimination of the thoracic and lumbar dermatomes Approximately 60 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Temperature discrimination
Description: Dermatomal evaluation of cold and warm discrimination of the thoracic and lumbar dermatomes Approximately 60 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pinprick test
Description: Dermatomal evaluation of pinprick/sharp sensation of the thoracic and lumbar dermatomes.~Approximately 60 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pinprick test
Description: Dermatomal evaluation of pinprick/sharp sensation of the thoracic and lumbar dermatomes.~Approximately 60 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood samples
Description: As a substudy the maximum serum concentration of ropivacaine is analyzed. Blood samples are taken at 0, 15, 30, 45 and 60 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Blood samples
Description: As a substudy the maximum serum concentration of ropivacaine is analyzed. Blood samples are taken at 0, 15, 30, 45 and 60 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Non-invasive blood pressure measurement
Description: Non-invasive blood pressure is measured prior to block administration and 30 minutes after block administration
Study NCT05023343 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Non-invasive blood pressure measurement
Description: Non-invasive blood pressure is measured prior to block administration and 30 minutes after block administration
Study NCT05683587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ballet course, strength course
Description: Include of two phase,first phase is strength course for three months and second phase is ballet course for three months.
Study NCT05326425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lazertinib(YH25448)
Description: - lazertinib 240mg(3tablets, 80mg/1tablet), once a day, oral, before disease progression
Study NCT06466863 — intervention group
Intervention type: OTHER
Intervention: Validity and Reliability
Description: Participants were included in the study after obtaining consent from both the participants and their parents. Participants were informed about the study prior to the survey, and only those who volunteered were included in the study. The data collection process was conducted online via Google Forms. The assessment form was sent to the participants through social media platforms, messages, and emails. Participants completed the YAP-T twice, 7 days apart, and all measurements were taken on weekdays under similar conditions by the same evaluators (4 evaluators) in the same region (Istanbul).~Test-retest reliability will be determined by calculating the Intraclass Correlation Coefficient (ICC) between the total scores obtained from the two assessments.
Study NCT06091761 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Auricular acupuncture
Description: Auricular acupuncture is conducted weekly in eight weeks using patches, each with a square shape and a side length of 10 mm, along with sterilized needles measuring 0.25 x 1.3 mm. Five acupoints on one ear are selected, which included Shen-men (TF4), Stomach (CO4), Spleen (CO13), Endocrine (CO18), and Hunger point. The patch with the needle will remain in place for one week.
Study NCT06091761 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Description: Auricular acupuncture is conducted weekly in eight weeks using patches, each with a square shape and a side length of 10 mm, along with sterilized needles measuring 0.25 x 1.3 mm. Five acupoints on one ear are selected, which included Shen-men (TF4), Stomach (CO4), Spleen (CO13), Endocrine (CO18), and Hunger point. The patch with the needle will remain in place for one week.
Study NCT06091761 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thread embedding acupuncture
Description: Thread embedding acupuncture is performed every two weeks in eight weeks using a single Polydioxaone thread. Needles has a gauge size of 29G, a shaft length of 38mm, and a thread length of 50mm, folded in half, and are applied to ten acupoints, including Qihai (CV6), Shuifen (CV9), and Tianshu (ST25), Shuidao (ST28), Daheng (SP15), Siman (KI14) on both sides of the body. Needles with a gauge size of 30G, a shaft length of 25mm, and a thread length of 30mm, folded in half, are used for five acupoints, which included Zhongwan (CV12) and Zusanli (ST36), Pishu (BL20) on both sides of the body. After the thread being inserted into the body, the needle will be withdrawn immediately.
Study NCT06091761 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Thread embedding acupuncture
Description: Sham Thread embedding acupuncture is performed every two weeks in eight weeks. Needles without threads has a gauge size of 29G, and a shaft length of 38mm, are applied to ten acupoints, including Qihai (CV6), Shuifen (CV9), and Tianshu (ST25), Shuidao (ST28), Daheng (SP15), Siman (KI14) on both sides of the body. Needles without threads with a gauge size of 30G, and a shaft length of 25mm, are used for five acupoints, which included Zhongwan (CV12) and Zusanli (ST36), Pishu (BL20) on both sides of the body. After the needle being inserted into the body, it will be withdrawn immediately.
Study NCT06313073 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiotherapy
Description: The patient received synchronous radiotherapy and chemotherapy before surgery. CTV : 40Gy/15fx/3w, sequential GTV： 8.7-10Gy/3-4 Fx.CTV : 40Gy/15fx/3w, sequential GTV： 8.7-10Gy/3-4 Fx.
Study NCT06313073 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: adjuvant radiotherapy
Description: The patient received radiotherapy after surgery. CTV : 40Gy/15fx/3w, sequential GTV： 8.7-10Gy/3-4 Fx.CTV : 40Gy/15fx/3w, sequential GTV： 8.7-10Gy/3-4 Fx.
Study NCT06312904 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: paravertebral block
Description: After cardiac surgery, the anesthesiologist will use 3mg/kg of 0.375% ropivacaine to conduct paravertebral block.